Modulation of myocardial energetics - Emerging evidence for a therapeutic target in cardiovascular disease

被引:57
作者
Morrow, DA
Givertz, MM
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, TIMI Study Grp, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Adv Heart Dis Program, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
editorials; angina; fatty acids; heart failure; ion channels;
D O I
10.1161/CIRCULATIONAHA.105.581819
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:3218 / 3221
页数:4
相关论文
共 21 条
[1]
[Anonymous], 2005, HEART DIS STROKE STA
[2]
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties [J].
Antzelevitch, C ;
Belardinelli, L ;
Zygmunt, AC ;
Burashnikov, A ;
Di Diego, JM ;
Fish, JM ;
Cordeiro, JM ;
Thomas, G .
CIRCULATION, 2004, 110 (08) :904-910
[3]
EFFECTS OF TRIMETAZIDINE ON ISCHEMIC CONTRACTURE IN ISOLATED-PERFUSED RAT HEARTS [J].
BOUCHER, FR ;
HEARSE, DJ ;
OPIE, LH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (01) :45-49
[4]
THERAPEUTIC VALUE OF A CARDIOPROTECTIVE AGENT IN PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY [J].
BROTTIER, L ;
BARAT, JL ;
COMBE, C ;
BOUSSENS, B ;
BONNET, J ;
BRICAUD, H .
EUROPEAN HEART JOURNAL, 1990, 11 (03) :207-212
[5]
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial [J].
Chaitman, BR ;
Pepine, CJ ;
Parker, JO ;
Skopal, J ;
Chumakova, G ;
Kuch, J ;
Wang, WD ;
Skettino, SL ;
Wolff, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (03) :309-316
[6]
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure [J].
Chandler, MP ;
Stanley, WC ;
Morita, H ;
Suzuki, G ;
Roth, BA ;
Blackburn, B ;
Wolff, A ;
Sabbah, HN .
CIRCULATION RESEARCH, 2002, 91 (04) :278-280
[7]
Defective cardiac ion channels: from mutations to clinical syndromes [J].
Clancy, CE ;
Kass, RS .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (08) :1075-1077
[8]
EFFICACY AND SAFETY OF PERHEXILINE-MALEATE IN REFRACTORY ANGINA - A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL OF A NOVEL ANTIANGINAL AGENT [J].
COLE, PL ;
BEAMER, AD ;
MCGOWAN, N ;
CANTILLON, CO ;
BENFELL, K ;
KELLY, RA ;
HARTLEY, LH ;
SMITH, TW ;
ANTMAN, EM .
CIRCULATION, 1990, 81 (04) :1260-1270
[9]
Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy [J].
Di Napoli, P ;
Taccardi, AA ;
Barsotti, A .
HEART, 2005, 91 (02) :161-165
[10]
Metabolic therapy for heart failure [J].
Essop, MF ;
Opie, LH .
EUROPEAN HEART JOURNAL, 2004, 25 (20) :1765-1768